The complexity of software architecture and diverse user interactions presents challenges to conventional testing approaches. Traditional test automation and quality assurance engineering represented ...

CHICAGO--(BUSINESS WIRE)-- Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced that the validation study of ...

Next-generation sequencing (NGS) has become increasingly popular with testing laboratories allowing them to obtain more data in less time and with minimal input. In this webinar we will explore the ...

The US Food and Drug Administration (FDA) on Wednesday finalized guidance to help industry develop and validate immune assays for the assessment of the immunogenicity of therapeutic protein products ...

The Single-antigen Bead (SAB) assay has revolutionized the detection of anti-HLA antibodies, which are critical in transplantation medicine. Despite its advantages, several limitations and challenges ...

Acquired CARD11 Mutation Promotes BCR Independence in Diffuse Large B Cell Lymphoma Despite the well-understood benefits of biomarker and genetic testing in precision medicine, uptake remains low, ...

For people with stable chest pain, a personalized "precision" testing approach led to more efficient evaluations for heart disease risk and improved diagnosis and treatment of coronary artery disease ...